(Q89983797)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32123307%20AND%20SRC:MED&resulttype=core&format=json

10 April 2020

title

Evaluating the efficacy of multiple myeloma cell lines as models for patient tumors via transcriptomic correlation analysis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32123307%20AND%20SRC:MED&resulttype=core&format=json

10 April 2020

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32123307%20AND%20SRC:MED&resulttype=core&format=json

10 April 2020

Arun P Wiita

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32123307%20AND%20SRC:MED&resulttype=core&format=json

10 April 2020

author name string

Vishesh Sarin

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32123307%20AND%20SRC:MED&resulttype=core&format=json

10 April 2020

Katharine Yu

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32123307%20AND%20SRC:MED&resulttype=core&format=json

10 April 2020

Ian D Ferguson

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32123307%20AND%20SRC:MED&resulttype=core&format=json

10 April 2020

Olivia Gugliemini

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32123307%20AND%20SRC:MED&resulttype=core&format=json

10 April 2020

Byron Hann

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32123307%20AND%20SRC:MED&resulttype=core&format=json

10 April 2020

Marina Sirota

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32123307%20AND%20SRC:MED&resulttype=core&format=json

10 April 2020

publication date

2 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32123307%20AND%20SRC:MED&resulttype=core&format=json

10 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32123307%20AND%20SRC:MED&resulttype=core&format=json

Malignant hematopoietic cell lines: in vitro models for the study of multiple myeloma and plasma cell leukemia

10 April 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FS41375-020-0785-1

7 January 2021

Targeting the bone marrow microenvironment in multiple myeloma.

1 reference

https://api.crossref.org/works/10.1038%2FS41375-020-0785-1

7 January 2021

Cell autonomous and microenvironmental regulation of tumor progression in precursor states of multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FS41375-020-0785-1

7 January 2021

Molecular pathogenesis of multiple myeloma and its premalignant precursor

1 reference

https://api.crossref.org/works/10.1038%2FS41375-020-0785-1

7 January 2021

Growth control mechanisms in multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FS41375-020-0785-1

7 January 2021

Interleukin-6-dependent gene expression profiles in multiple myeloma INA-6 cells reveal a Bcl-2 family-independent survival pathway closely associated with Stat3 activation

1 reference

https://api.crossref.org/works/10.1038%2FS41375-020-0785-1

7 January 2021

Biologic sequelae of interleukin-6 induced PI3-K/Akt signaling in multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FS41375-020-0785-1

7 January 2021

Preclinical studies of fibroblast growth factor receptor 3 as a therapeutic target in multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FS41375-020-0785-1

7 January 2021

The Bcl-2 specific BH3 mimetic ABT-199: a promising targeted therapy for t(11;14) multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FS41375-020-0785-1

7 January 2021

Relating hepatocellular carcinoma tumor samples and cell lines using gene expression data in translational research

1 reference

https://api.crossref.org/works/10.1038%2FS41375-020-0785-1

7 January 2021

A variance-stabilizing transformation for gene-expression microarray data

1 reference

https://api.crossref.org/works/10.1038%2FS41375-020-0785-1

7 January 2021

Multiple myeloma immunoglobulin lambda translocations portend poor prognosis

1 reference

https://api.crossref.org/works/10.1038%2FS41375-020-0785-1

7 January 2021

Genetic and transcriptional evolution alters cancer cell line drug response

1 reference

https://api.crossref.org/works/10.1038%2FS41375-020-0785-1

7 January 2021

Multi-omic measurements of heterogeneity in HeLa cells across laboratories

1 reference

https://api.crossref.org/works/10.1038%2FS41375-020-0785-1

7 January 2021

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity

1 reference

https://api.crossref.org/works/10.1038%2FS41375-020-0785-1

7 January 2021

Establishment of five human myeloma cell lines

1 reference

https://api.crossref.org/works/10.1038%2FS41375-020-0785-1

7 January 2021

Production of free light chains of immunoglobulin by a hematopoietic cell line derived from a patient with multiple myeloma.

1 reference

https://api.crossref.org/works/10.1038%2FS41375-020-0785-1

7 January 2021

Xbp1s-negative tumor B cells and pre-plasmablasts mediate therapeutic proteasome inhibitor resistance in multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FS41375-020-0785-1

7 January 2021

Extensive immunoglobulin production sensitizes myeloma cells for proteasome inhibition.

1 reference

https://api.crossref.org/works/10.1038%2FS41375-020-0785-1

7 January 2021

Proteasome inhibitors induce a terminal unfolded protein response in multiple myeloma cells

1 reference

https://api.crossref.org/works/10.1038%2FS41375-020-0785-1

7 January 2021

Lessons Learned from Proteasome Inhibitors, the Paradigm for Targeting Protein Homeostasis in Cancer

1 reference

https://api.crossref.org/works/10.1038%2FS41375-020-0785-1

7 January 2021

Initial genome sequencing and analysis of multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FS41375-020-0785-1

7 January 2021

Widespread genetic heterogeneity in multiple myeloma: implications for targeted therapy

1 reference

https://api.crossref.org/works/10.1038%2FS41375-020-0785-1

7 January 2021

Identification of novel mutational drivers reveals oncogene dependencies in multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FS41375-020-0785-1

7 January 2021

Interpretation of cytogenetic results in multiple myeloma for clinical practice

1 reference

https://api.crossref.org/works/10.1038%2FS41375-020-0785-1

7 January 2021

The molecular classification of multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FS41375-020-0785-1

7 January 2021

Repurposing tofacitinib as an anti-myeloma therapeutic to reverse growth-promoting effects of the bone marrow microenvironment.

1 reference

https://api.crossref.org/works/10.1038%2FS41375-020-0785-1

7 January 2021

Gene expression profiling for molecular classification of multiple myeloma in newly diagnosed patients

1 reference

https://api.crossref.org/works/10.1038%2FS41375-020-0785-1

7 January 2021

Introduction of an activated N-ras oncogene alters the growth characteristics of the interleukin 6-dependent myeloma cell line ANBL6.

1 reference

12 December 2020

Interleukin-6 in human multiple myeloma.

1 reference

12 December 2020

Coexistence of aneuploid subclones within a myeloma cell line that exhibits clonal immunoglobulin gene rearrangement: clinical implications

1 reference

12 December 2020

Activating mutations in the N- and K-ras oncogenes differentially affect the growth properties of the IL-6-dependent myeloma cell line ANBL6.

1 reference

12 December 2020

Fluorescence imaging of multiple myeloma cells in a clinically relevant SCID/NOD in vivo model: biologic and clinical implications

1 reference

12 December 2020

Evaluating cell lines as models for metastatic breast cancer through integrative analysis of genomic data

1 reference

12 December 2020

Comprehensive transcriptomic analysis of cell lines as models of primary tumors across 22 tumor types

1 reference

12 December 2020